Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
about
High-priority drug–drug interactions for use in electronic health recordsDrug interactions with warfarin: what clinicians need to knowCriteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health recordsPrevalence of the prescription of potentially interacting drugsDrug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic review.Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews.Expected and actual adverse drug-drug interactions in elderly patients accessing the emergency department: data from the ANCESTRAL-ED study.Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D.Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software.Prescribing quality in older veterans: a multifocal approachUnderstanding and preventing drug-drug and drug-gene interactions.Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactionsDesigning concept maps for a precise and objective description of pharmaceutical innovations.Evaluation of a drug-drug interaction: fax alert intervention program.Safety and effectiveness of mail order pharmacy use in diabetes.Assessment of the consistency among three drug compendia in listing and ranking of drug-drug interactionsHealthcare professional students' knowledge of drug-drug interactionsComparative assessment of four drug interaction compendia.Evaluation of a drug-drug interaction alert structure through the retrospective analysis of statins-macrolides co-prescriptions.Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.Physicians' response to computerised alerts for psychotropic drugs in older persons: a multilevel analysis of the associated alert, patient and physician characteristics.Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.Incidence rate and pattern of clinically relevant potential drug-drug interactions in a large outpatient population of a developing country.Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals.Detection of potential drug-drug interactions for outpatients across hospitals.Potentially inappropriate medications in the elderly: a comprehensive protocol.Clinical implications from drug-drug and drug-disease interactions in older people.Prevalence of potentially serious drug-drug interactions among South African elderly private health sector patients using the Mimica Matanović/Vlahović-Palčevski protocol.Prevalence and nature of potential drug-drug interactions among kidney transplant patients in a German intensive care unit.Evaluation of resources for analyzing drug interactions.Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System).A New Computer-Based Tool to Reduce Potentially Inappropriate Prescriptions in Hospitalized Geriatric Patients.Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis.Prevalence of Potential and Clinically Relevant Statin-Drug Interactions in Frail and Robust Older Inpatients.Evaluation of drug interaction software to identify alerts for transplant medications.Metal allergy screening prior to joint arthroplasty and its influence on implant choice: a delphi consensus study amongst orthopaedic arthroplasty surgeons.Medical, nursing, and pharmacy students' ability to recognize potential drug-drug interactions: a comparison of healthcare professional students.Use of an on-demand drug-drug interaction checker by prescribers and consultants: a retrospective analysis in a Swiss teaching hospital.Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug-drug interactions.
P2860
Q17505343-37692F77-F1CB-405D-890B-3639A70F7C7EQ24681312-10A5C85E-CEDB-4F2B-A485-D86828B41844Q26999857-AC33B465-155C-4B58-AC3F-C62B99F0A150Q28534352-1A5081FE-A1CE-493F-8ADC-E523A4A03F67Q30488323-E051CA6D-351A-4F6E-AF4F-E93F5D3E738CQ30839776-46A82F30-BF54-4154-8DFD-37FA33FC75AFQ31144138-D5276092-31DB-4611-BF19-E715661B2227Q33969482-A037A9EA-43AD-4A31-B467-C3B008835245Q34002440-5E5AB23F-E888-4A53-86D3-84BF34322D9DQ34246616-55124079-3643-4DEC-9640-B8773F896E9CQ34415944-BF684506-C593-4C61-9896-6E3B01F06057Q34424127-EC504F3C-AB93-422F-A109-28EAA6D617DAQ34554266-311C068C-E5F0-4CF9-892E-DC94A6B9ADF4Q34623440-879C8A50-164A-4CC0-92BB-A9D4ABAF5DFBQ34782693-A80B9358-92D0-4771-ACF9-67A61942F4CFQ35100012-2BA0E859-C738-4D30-A169-60E63D9172C2Q35755542-E5C050A6-BFF1-4D16-9BEB-4482F760235EQ36024425-88B26B3C-2231-4BE7-A096-F72F0FB9D620Q36065199-3DFA545A-F10D-4372-B3CF-4D2F0934CB81Q36219247-E5259B7D-8447-474F-A274-9B6991482335Q36370235-2DD3CF49-8FF7-46F0-94A9-DDEB15DA13C7Q36410106-EBED5A53-EE09-48DE-AE29-07FDDD496DCCQ37129099-2B6307A4-0280-4860-8947-CA67389E4331Q37334707-8005D026-0223-4A96-A1AD-1400F663A143Q37592428-D22F46C7-6003-4358-AB5E-3B96D017FF59Q37622976-10BD6414-7264-4D40-9CE5-E8E995554226Q37987859-FBC31F49-6AAE-4299-AC3E-E0CB61267EC8Q38092903-9F57DEEC-0BAE-432B-8F1D-E3C52AC833CBQ38400290-88DAC874-A53C-43BD-8321-DC600AE9A6F1Q38617390-D88C0E4D-DA86-42B0-A2E3-6BDD6B98AC9CQ39206808-28BE17D1-5EC9-418D-93A6-96700F207536Q39726852-24237184-3939-4D92-92C0-E68C846573DBQ40081064-F8DD46F4-F497-4F9A-B2DF-469A35118FBCQ40156505-FA947B9A-3DE9-4DD5-A679-DEC2268C4027Q40459838-8B0EBC69-B2B8-45F0-AA86-EA66238649E2Q40461039-ECA5720B-DA80-4FF6-8C99-69732C0A38FEQ42786277-9DF6D0A4-0F0B-4CA4-B8EA-F035F03D0771Q43673316-98037C53-7510-417C-968E-B2BEB1AD775AQ43898021-A302DAA7-9A19-4CF1-8C7F-0CD2DA3015E9Q43907965-977FA07B-018E-4FDF-A5C6-931332E339B5
P2860
Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Identification of serious drug ...... revent drug-drug interactions.
@ast
Identification of serious drug ...... revent drug-drug interactions.
@en
type
label
Identification of serious drug ...... revent drug-drug interactions.
@ast
Identification of serious drug ...... revent drug-drug interactions.
@en
prefLabel
Identification of serious drug ...... revent drug-drug interactions.
@ast
Identification of serious drug ...... revent drug-drug interactions.
@en
P2093
P1476
Identification of serious drug ...... revent drug-drug interactions.
@en
P2093
Amy J Grizzle
Babette S Duncan-Edgar
Daniel C Malone
Edward P Armstrong
Jacob Abarca
Philip D Hansten
Robin C Van Bergen
Steven L Solomon
P304
P356
10.1331/154434504773062591
P577
2004-03-01T00:00:00Z